Skip to main content
SpringerLink
Log in

Use of Plasma Volume Expanders in Myocardial Revascularisation

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The optimal solution for priming cardiopulmonary bypass machines and for postoperative resuscitation following myocardial revascularisation should be inexpensive, free of risk of transmitting disease, and free of other detrimental side effects. Colloid solutions are preferred over crystalloid solutions because of elevations in extracellular sodium and water that occur with cardiopulmonary bypass.

Albumin, plasma protein solution, hetastarch (hydroxyethyl starch) and dextran are available for use if blood is not necessary and mediastinal blood is not available. Hetastarch is associated with a lower risk of bleeding and less risk of allergic reaction than dextran, and its cost is substantially less than that of albumin. However, high doses increase the risk of bleeding complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aberg M, Hedner U, Bergentz SE. Effect of dextran on factor VIII (antihemophilic factor) and platelet function. Annals of Surgery 189: 243–247, 1977

    Article  Google Scholar 

  • Alving BM, Hojima Y, Pisano JJ, Mason BL, Finlayson JS. Hypotension associated with prekallikrein activator (Hagemon-factor fragments) in plasma protein fraction. New England Journal of Medicine 299: 66–70, 1978

    Article  PubMed  CAS  Google Scholar 

  • Belcher P, Lennox SG. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Annals of Thoracic Surgery 37: 674–679, 1982

    Google Scholar 

  • Bland JHL, Laver MB, Lowenstein E. Vasodilator effect of commercial 5% plasma protein fraction solutions. Journal of the American Medical Association 224: 1721–1724, 1973

    Article  PubMed  CAS  Google Scholar 

  • Damon L, Adams M, Stricher RB, Ries C. Intracranial bleeding during treatment with hydroxyethyl starch. New England Journal of Medicine 317: 964–965, 1987

    PubMed  CAS  Google Scholar 

  • Diehl JT, Lester JL, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Annals of Thoracic Surgery 34: 674–679, 1982

    Article  PubMed  CAS  Google Scholar 

  • Falk JL, Rackon EC, Astiz ME, Weil MH. Effects of hetastarch and albumin on coagulation in patients with septic shock. Journal of Clinical Pharmacology 28: 412–415, 1988

    PubMed  CAS  Google Scholar 

  • Gallagher JD, Moore RA, Kerns D, Jose AB, Clark DL, et al. Effects of colloid and crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesthesia and Analgesia 64: 753–758, 1985

    PubMed  CAS  Google Scholar 

  • Hulse JD, Yacobi A. Hetastarch: An overviewing of the colloid and its metabolism. Drug Intelligence and Clinical Pharmacology 17: 334–34, 1983

    CAS  Google Scholar 

  • Khosropour R, Lackner F, Steinbereithner K, Watzek C, Piza F, et al. Comparison of effects of hydroxyethyl starch (HES200/ 0.5) administered pre-and postoperative in vascular surgery with dextran 40 (60). Anaesthesist 29: 616–622, 1980

    PubMed  CAS  Google Scholar 

  • Kirklin JW, Kirklin JK, Lell WA. Cardiopulmonary bypass for cardiac surgery. In Sabiston DC & Spencer FC (Eds) Gibbon’s surgery of the chest, 4th ed., pp. 909–925, WB Saunders, Philadelphia, 1983

    Google Scholar 

  • Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch verses albumin for colloid infusions following cardiopulmonary bypass in patients undergoing myocardial revascularization. Annals of Thoracic Surgery 37: 40–46, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kohler H, Kirch W, Horstmann HJ. Hydroxyethyl starch-induced macroamylasemia. International Journal of Clinical Pharmacology 15: 428–431, 1977

    CAS  Google Scholar 

  • Kohler H, Zschiedrich H, Classen R, Linfante A, Gamm H. The effects of 500ml 10% hydroxyethyl starch 100/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure, and renal function in normal human volunteers. Anaesthetist 31: 61–67, 1982

    CAS  Google Scholar 

  • Lamke LO, Liljedahl SO. Plasma volume changes after infusion of various plasma expanders. Resuscitation 5: 93–102, 1976

    Article  PubMed  CAS  Google Scholar 

  • Lee WH Jr, Rubin JW, Huggins MP. Clinical evaluation of priming solutions for pump oxygenator perfusion. Annals of Thoracic Surgery 19: 529–536, 1975

    Article  PubMed  Google Scholar 

  • Lewis JH, Szeto ILF, Bayer WL, Takaori M, Safer D. Severe hemodilution with hydroxyethyl starch and dextrans. Archives of Surgery 93: 941–950, 1966

    Article  PubMed  CAS  Google Scholar 

  • London MJ, Ho JS, Triedman JK, Verrier ED. Mongano DT, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. Journal of Thoracic and Cardiovacular Surgery 97: 785–97, 1989

    CAS  Google Scholar 

  • Long DM Jr, Sanchez L, Varco RL, Lillehei CW. The use of low molecular weight dextran and serum albumin as plasma expanders in extracorporeal circulation. Surgery 50: 12–28, 1961

    PubMed  CAS  Google Scholar 

  • Lutz H, Georgieff M. Effects and side effects of colloid plasma substitutes compared to albumin. Current Studies of Hematology and Blood Transfusion 53: 145–154, 1986

    Google Scholar 

  • Metcalf W, Dargan EL, Hehre EJ, Levitsky S, Dibuono TJ. Clinical physiological Characterization of a new dextran. Surgery Gynecology and Obstetrics 115: 199–206, 1962

    CAS  Google Scholar 

  • Moggio RA, Chan C, Somberg ED, Praeger PI, Reed GE, et al. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Critical Care Medicine 11: 943–945, 1983

    Article  PubMed  CAS  Google Scholar 

  • Munsch CM, MacIntyre E, Machin SJ, Mackie IJ, Treasure T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. British Journal of Surgery 75: 675–678, 1988

    Article  PubMed  CAS  Google Scholar 

  • Olinger GN, Werner PH, Bonchek LI, Boerboom LE. Vasodilator effects of sodium acetate in the pooled protein fraction. Annals of Surgery 190: 305–311, 1979

    Article  PubMed  CAS  Google Scholar 

  • Pacifico AD, Digerness S, Kirklin JW. Acute alterations of body composition after open cardiac operations. Circulation 41: 331–341, 1970

    Article  PubMed  CAS  Google Scholar 

  • Packman MA, Evans G, Glynn MF, Mustard JF. The effect of plasma proteins on the interaction of platelets with glass surfaces. Journal of Laboratory and Clinical Medicine 73: 686–697, 1969

    Google Scholar 

  • Palanzo DA, Parr GVS, Bull AP, Williams DR, O’Neill MJ, et al. Hetastarch as a prime for cardiopulmonary bypass. Annals of Thoracic Surgery 34: 680–683, 1982

    Article  PubMed  CAS  Google Scholar 

  • Porter SS, Goldberg RJ. Intraoperative allergic reactions to hydroxyethyl starch: a report of two cases. Canadian Anaesthetists’ Society Journal 33: 394–398, 1986

    Article  PubMed  CAS  Google Scholar 

  • Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466–469, 1977

    Article  PubMed  CAS  Google Scholar 

  • Saddler JM, Horsey PF. The new generation gelatins: A review of their history, manufacture and properties. Anaesthesia 42: 998–1004, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, et al. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer’s solution as priming fluid for cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery 89: 713–722, 1985

    PubMed  CAS  Google Scholar 

  • Saunders CR, Carlisle L, Bick RL. Hydroyethyl starch verses albumin in cardiopulmonary bypass prime solutions. Annals of Thoracic Surgery 36: 532–539, 1983

    Article  PubMed  CAS  Google Scholar 

  • Shutney C, Deepika K, Militello PR, Majerus TC, Dawson B. Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock. Archives of Surgery 118: 804–809, 1983

    Article  Google Scholar 

  • Strauss RG, Stansfield C, Henriksen RA, Villhauer PG. Pentastarch may cause fewer adverse effects on coagulation than hetastarch. Transfusion 28: 257–260, 1988

    Article  PubMed  CAS  Google Scholar 

  • Strauss RG, Stump DG, Henrikson RA, Saunders R. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 25: 230–234, 1985

    Article  PubMed  CAS  Google Scholar 

  • Stump DC, Strauss RG, Henrikson RA, Petersen RE, Saudners R. Effects of hydroxyethyl strch on blood coagulation, particularly factor VIII. Transfusion 25: 349–354, 1985

    Article  PubMed  CAS  Google Scholar 

  • Symington BE. Hetastarch and bleeding complications. Annals of Internal Medicine 105: 627–628, 1986

    PubMed  CAS  Google Scholar 

  • Thompson WL. Rational use of albumin and plasma substitutes. The Johns Hopkins Medical Journal 136: 220–225, 1975

    PubMed  CAS  Google Scholar 

  • Thompson WL, Britton JJ, Walton RP. Persistence of starch derivatives and dextran when infused after hemorrhage. Journal of Pharmacology and Experimental Therapeutics 136: 126–132, 1962

    Google Scholar 

  • Verska JJ, Ludington LG, Brewer LA. A comparative study of cardiopulmonary bypass with nonblood and blood prime. Annals of Thoracic Surgery 18: 72–80, 1974

    Article  PubMed  CAS  Google Scholar 

  • Yacobi A, Stoll RG, Sum Cy, Lai CM, Gupta SD, et al. Pharmocokinetics of hydroxyethyl starch in normal subjects. Journal of Clinical Pharmacology 22: 206–212, 1982

    PubMed  CAS  Google Scholar 

  • Zuhdi N, McCollough B, Carey J, Kriger C, Greer A. Hypothermic perfusion for open-heart surgical procedures: report on the use of a heart-lung machine primed with 5% dextrose in water inducing hemodilution. Journal of the International College of Surgeons 35: 319–326, 1961

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The Jewish Hospital of Cincinnati, 3200 Burnette Avenue, Cincinnati, Ohio, OH 45229, USA

    John H. Lacy & Creighton B. Wright

Authors
  1. John H. Lacy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Creighton B. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lacy, J.H., Wright, C.B. Use of Plasma Volume Expanders in Myocardial Revascularisation. Drugs 44, 720–727 (1992). https://doi.org/10.2165/00003495-199244050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199244050-00004

Keywords

Search

Navigation